Align Technology (NASDAQ:ALGN – Get Free Report) will release its quarterly earnings data after the market close on Wednesday, July 24. Analysts expect the company to report earnings of $2.33 per share for the quarter. Align Technology has set its fiscal 2024 EPS guidance and its second-quarter 2024 EPS guidance. Parties wishing to register for the company’s conference call can do so using this link.
Align Technology (NASDAQ:ALGN – Get Free Report) released its latest quarterly earnings data on Wednesday, April 24th. The medical equipment provider reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.08. Align Technology had a net margin of 11.80% and a return on equity of 14.15%. The company had revenue of $997.43 million for the quarter, compared to analysts’ expectations of $971.97 million. On average, analysts expect Align Technology to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.
Align Technology Price Performance
ALGN stock opened at $247.54 on Wednesday. The company has a 50-day moving average price of $254.19 and a 200-day moving average price of $282.09. The stock has a market cap of $18.64 billion, a price-to-earnings ratio of 40.78, a P/E/G ratio of 4.48, and a beta of 1.66. Align Technology has a 52-week low of $176.34 and a 52-week high of $413.20.
Analysts set new price targets
Several research firms have recently weighed in on ALGN. Morgan Stanley increased their price target on Align Technology from $344.00 to $360.00 and gave the stock an “overweight” rating in a research report on Thursday, April 25th. UBS Group increased their price target on Align Technology from $280.00 to $320.00 and gave the stock a “neutral” rating in a research report on Monday, April 15th. OTR Global reaffirmed a “mix” rating on shares of Align Technology in a research note on Tuesday, June 4th. Robert W. Baird increased their price target on Align Technology from $333.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday, April 25th. Finally, Evercore ISI lowered their price objective on shares of Align Technology from $370.00 to $300.00 and set an “outperform” rating on the stock in a research note on Monday, June 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $346.50.
Check out our latest stock analysis for Align Technology
About Align Technology
(Get the free report)
Align Technology, Inc. designs, manufactures and markets Invisalign clear aligners and iTero intraoral scanners and services to orthodontists and general dentists in the United States, Switzerland and internationally. The company’s Clear Aligner segment offers comprehensive products, including the Invisalign Comprehensive Package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators and compensation for tooth eruption; and the Invisalign First Phase I and Invisalign First Comprehensive Phase 2 packages for younger patients, typically between six and ten years of age, which is a mix of primary/baby and permanent teeth.
See too
Get daily news and reviews from Align Technology – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Align Technology and related companies with MarketBeat.com’s FREE daily newsletter.
